Coinbase Global IncBitcoin surge driven by Treasury buyback and supportive Trump comments lifts Coinbase.
Moderna delivered one of the largest single-session moves for an S&P 500 company, closing 177% higher at $174.38 on Wednesday after reporting positive late-stage data for its personalized cancer vaccine. The stock pulled back over 23% on Thursday before adding more than 10% so far on Friday, leaving it on course for a gain of around 135% over the week. The Phase 3 trial evaluated Moderna's intismeran alongside Merck's Keytruda in advanced skin cancer, and met its primary goal of recurrence-free survival, with a key secondary endpoint on distant metastasis-free survival also met and no new safety signal reported. Crypto-exposed equities rallied hard this week after bitcoin surged on the U.S. Treasury's decision to at least double the size of its long-dated bond buyback operations, alongside supportive comments on the sector from President Donald Trump. The Treasury raised the maximum per-operation size from $2 billion to at least $4 billion for the 10-to-20-year and 20-to-30-year sectors, effective Sept. 9 through Nov. 4. Bitcoin is currently above $77,000, having hit a high of $79,461 earlier in Friday's session. As a result, Strategy has risen 25.9% over the week, with Marathon Digital up 22.5%, Coinbase 23.1% higher, Circle up 16.3%, Galaxy Digital 12.3% higher and Robinhood up 9.7%. The same Treasury announcement also lifted metals producers, with the dollar weakening and precious metal prices moving higher. Agnico Eagle leads the group so far on Friday with an 18.4% gain over the week, followed by Barrick at 15%, Freeport-McMoRan up 14% and Newmont 13.3% higher. The dollar has declined, with spot gold gaining more than 2% on Friday and over 6% in the past week. Estée Lauder jumped more than 16% on Wednesday and is set to finish the week up around 15.9% after fourth-quarter results came in ahead of expectations. Sales rose 6%, beating consensus of 4%, while adjusted earnings of $0.39 per share topped the $0.32 expected. Management pointed to share gains in mainland China and growth across all product categories except hair care, alongside continued progress on cost-cutting through its One ELC initiative and Profit Recovery and Growth Plan. Canaccord analyst Susan Anderson raised her price target for the stock to $90 from $85, maintaining a Hold rating following the release. Walmart is the week's notable loser, sinking 9.2% on Thursday and down a further 0.9% so far on Friday after second-quarter results that beat on the headline numbers but disappointed on the metric that mattered most. Comparable sales at Walmart-only U.S. stores excluding gas grew 2.6%, well short of the 3.67% consensus and the slowest U.S. sales growth in six years. Mizuho analyst David Bellinger described the outcome as a worst-case scenario, calling it a very messy print and one of the biggest misses in years from the retailer.
Coinbase Global IncBitcoin surge driven by Treasury buyback and supportive Trump comments lifts Coinbase.
Circle Internet Group, Inc.Bitcoin rally from Treasury buyback and Trump support boosts Circle.
MicroStrategy IncorporatedTreasury's bond buyback expansion weakens dollar, boosting bitcoin and crypto-exposed stocks like MicroStrategy.
Galaxy Digital Holdings LtdBitcoin surge on Treasury buyback and Trump comments lifts crypto-exposed equities.
Robinhood Markets IncBitcoin surge on Treasury buyback and Trump comments lifts crypto-exposed equities.
Marathon Digital Holdings IncBitcoin surge on Treasury buyback and Trump comments lifts crypto-exposed equities.
Agnico Eagle Mines LimitedTreasury buyback expansion weakens dollar, boosting gold prices and Agnico Eagle.
Barrick Mining CorporationDollar weakness from Treasury buyback lifts gold, benefiting Barrick.
Freeport-McMoran Copper & Gold IncTreasury bond buyback expansion weakens dollar, boosting metals prices.
Newmont Goldcorp CorpDollar weakness from Treasury's buyback expansion lifts precious metals, benefiting Newmont.
Merck KGaA
Moderna IncPositive Phase 3 data for personalized cancer vaccine drives stock surge.
Merck & Company Inc
Estee Lauder Companies IncEstée Lauder jumps 16% on strong fourth-quarter earnings.
Walmart Inc.
Gold.com, Inc.